This effect was also dramatically seen in two PDX models of metastatic OS with high MYC copy number as well as two pancreatic ductal adenocarcinoma (PDAC) cell lines driven by KRAS mutation and MYC amplification. Here, MYC is linked to pancreatic ductal adenocarcinoma.